about
A phase 2 study of nanoparticle albumin-bound paclitaxel plus nedaplatin for patients with advanced, recurrent, or metastatic cervical carcinoma.Zeylenone, a naturally occurring cyclohexene oxide, inhibits proliferation and induces apoptosis in cervical carcinoma cells via PI3K/AKT/mTOR and MAPK/ERK pathways.Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience.PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway.A molecular understanding of D-homoestrone-induced G2/M cell cycle arrest in HeLa human cervical carcinoma cellsPotential impact of mTOR inhibitors on cervical squamous cell carcinoma: A systematic review.BRIP1 inhibits the tumorigenic properties of cervical cancer by regulating RhoA GTPase activityNovel approaches for concurrent irradiation in locally advanced cervical cancer: platinum combinations, non-platinum-containing regimens, and molecular targeted agents.Evaluation of the efficacy of chemoradiotherapy in cervical cancer using diffusion-weighted imaging and apparent diffusion coefficient.A Review of mTOR Pathway Inhibitors in Gynecologic CancerPharmacotherapy of cervical cancer.Epidermal growth factor receptor as a biomarker for cervical cancer.Chemoradiation in the management of cervix cancer: current status and future directions.Signaling pathways in HPV-associated cancers and therapeutic implications.Mutation analysis of EGFR and its correlation with the HPV in Indian cervical cancer patients.Synergistic effect of pyrrolidine dithiocarbamate and cisplatin in human cervical carcinoma.Inhibition of COX2 enhances the chemosensitivity of dichloroacetate in cervical cancer cellsStreptomyces sp metabolite(s) promotes Bax mediated intrinsic apoptosis and autophagy involving inhibition of mTOR pathway in cervical cancer cell lines.Combined measurement of tumor perfusion and glucose metabolism for improved tumor characterization in advanced cervical carcinoma. A PET/CT pilot study using [15O]water and [18F]fluorodeoxyglucose.A prospective study on neoadjuvant chemoradiotherapy plus anti-EGFR monoclonal antibody followed by surgery for locally advanced cervical cancer.Liposomes Loaded with Cisplatin and Magnetic Nanoparticles: Physicochemical Characterization, Pharmacokinetics, and In-Vitro Efficacy
P2860
Q33435722-95A29AD9-DA23-4695-9B91-5217B184BEFFQ33687272-A315014E-AEA8-49D4-9676-5AC0CF2F8CF0Q34957243-AD33E30B-9A01-4171-9EBC-710ABC891A14Q36096924-5E092A44-7D0E-4468-BF43-14C7E7184590Q36125367-21179866-B480-4857-A3DF-C7AFCEC6458BQ36206239-2C7E542D-F1E0-4EE5-BEF2-1B27CF29D699Q36502747-BD8AE003-9F36-4590-BF78-4C10BB3D3AEDQ36908043-F8195744-5278-4D74-B021-DE1FAA0D4F20Q37515721-69852048-2FCC-4143-B66F-D2897D8F61B6Q37668889-42E1F1DF-FBB5-41DD-B770-056336933D59Q37773995-EB5C30F8-7737-437E-8DF2-ED6C7A35B483Q37843137-6C3B3122-4617-4F7B-ACD1-A3101FD28D4EQ38079973-92F006AF-ED6B-4671-A81B-B7D17DE5C5A9Q38370778-6694B380-CF32-4EED-A19A-B0D8F67DC399Q38804094-9078F8A7-66EF-4903-A1EE-B189B26FC1ADQ39018631-D79F7C32-24FF-4AF4-9F39-78303BA77880Q41612999-A6942B3C-42B3-4222-960A-16A552721365Q49790489-44DA7DEE-F7F2-4418-AF9F-8E149ED6E3FBQ51591829-C7B3F4D1-9DED-4200-BC34-3787ADD08631Q55717412-CC534518-C9A2-4062-8C2C-A4806EB534D1Q58691838-CD9028DD-B234-4EAD-9BCF-ED395D3068FA
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel chemotherapy approaches for cervical cancer.
@en
Novel chemotherapy approaches for cervical cancer.
@nl
type
label
Novel chemotherapy approaches for cervical cancer.
@en
Novel chemotherapy approaches for cervical cancer.
@nl
prefLabel
Novel chemotherapy approaches for cervical cancer.
@en
Novel chemotherapy approaches for cervical cancer.
@nl
P2860
P356
P1433
P1476
Novel chemotherapy approaches for cervical cancer
@en
P2093
Lorna Rodriguez
Sujana Movva
P2860
P304
P356
10.1002/CNCR.24364
P407
P577
2009-07-01T00:00:00Z